Daiichi Sankyo's Patent Suits V. Mylan Combined

Law360, New York (July 3, 2008, 12:00 AM EDT) -- Daiichi Sankyo Co. Ltd.'s patent infringement suit against Mylan Pharmaceuticals Inc. over the hypertension drug Azor has been consolidated with another dispute between the companies over a related drug.

In an order filed Wednesday in the U.S. District Court for the District of New Jersey, Magistrate Judge Mark Falk combined the suit with a 2006 suit over Benicar, a Daiichi Sankyo drug that contains one of the two active ingredients in Azor.

Tokyo-based Daiichi Sankyo and Mylan agreed in the stipulated order that no further discovery...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.